SonoSite Third Quarter Revenue Rises 23%
16 October 2008 - 7:20AM
Business Wire
SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in
hand-carried ultrasound for the point-of-care, said today that
revenue grew approximately 23% to over $61 million in the third
quarter, ended September 30, 2008, compared to the same quarter in
2007 and that the company expects to exceed consensus earnings
estimates with strong cash flow. Third quarter financial results
are preliminary. The company will report third quarter and nine
months financial results on Thursday, October 30, 2008 at the close
of market. Third Quarter Conference Call Information Management
will hold a conference call on October 30, 2008 at 1:30 pm PT/4:30
pm ET to discuss the quarter�s results. The call will be broadcast
live and can be accessed via the �Investors� Section of SonoSite�s
website at www.sonosite.com. A replay of the audio webcast will be
available beginning October 30, 2008, 4:30 pm PT and will be
available until November 13, 2008, midnight PT by dialing
719-457-0820 or toll-free 888-203-1112. The confirmation code
4566842 is required to access the replay. The call will also be
archived on SonoSite�s website. About SonoSite SonoSite, Inc.
(www.sonosite.com) is the innovator and world leader in
hand-carried ultrasound. Headquartered near Seattle, the company is
represented by ten subsidiaries and a global distribution network
in over 100 countries. SonoSite�s small, lightweight systems are
expanding the use of ultrasound across the clinical spectrum by
cost-effectively bringing high performance ultrasound to the point
of patient care. The company employs over 600 people worldwide.
Forward-looking Information and the Private Litigation Reform Act
of 1995 Certain statements in this press release relating to the
market acceptance of our products, possible future sales relating
to expected orders, and our future financial position and operating
results are �forward-looking statements� for the purposes of the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. These forward-looking statements are based on the
opinions and estimates of our management at the time the statements
are made and are subject to risks and uncertainties that could
cause actual results to differ materially from those expected or
implied by the forward-looking statements. These statements are not
guaranties of future performance and are subject to known and
unknown risks and uncertainties and are based on potentially
inaccurate assumptions. Factors that could affect the rate and
extent of market acceptance of our products, the receipt of
expected orders, and our financial performance include our ability
to successfully manufacture, market and sell our ultrasound
systems, our ability to accurately forecast customer demand for our
products, our ability to manufacture and ship our systems in a
timely manner to meet customer demand, variability in quarterly
results caused by the timing of large project orders from
governmental or international entities and the seasonality of
hospital purchasing patterns, timely receipts of regulatory
approvals to market and sell our products, regulatory and
reimbursement changes in various national health care markets,
constraints in government and public health spending, the ability
of our distribution partners and other sales channels to market and
sell our products and any changes to such channels, the impact of
patent litigation, our ability to execute our acquisition strategy,
the effect of transactions and activities associated with our
issuance of senior convertible debt in July 2007 on the market
price of our common stock, and as well as other factors contained
in the Item 1A. �Risk Factors� section of our most recent Annual
Report on Form 10-K filed with the Securities and Exchange
Commission. We caution readers not to place undue reliance upon
these forward-looking statements that speak only as to the date of
this release. We undertake no obligation to publicly revise any
forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated events.
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024